ArticleEuropean urology2023

Re: Khyati Meghani, Lauren Folgosa Cooley, Bonnie Choy, et al. First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin. Eur Urol. 2022;82:602-10.

Ryan L Steinberg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.